Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Novel DehydraTECH(TM) Technology to Address Unmet Antihypertension Drug Market
Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illnessThe antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and diagnostic agentsValued at US $30.2 billion in 2021, the market is expected to grow at a CAGR of 3%, resulting in a value of US $40 billion by 2031Lexaria’s patented DehydraTECH(TM)…